84803-56-5

Usage

InChI:InChI=1/C9H13NO/c1-11-7-6-8-2-4-9(10)5-3-8/h2-5H,6-7,10H2,1H3

Upstream product

• 66821-15-6 1-(2-methoxyethenyl)-4-nitrobenzene 
• 100-27-6 2-(4-nitrophenyl)ethanol 
• 60835-90-7 p-bromo-β-methoxyethylbenzene 
• 4654-39-1 4-bromophenethanol 
• 41841-16-1 (4-bromo-phenyl)-acetic acid methyl ester 
• 1878-68-8 2-(4-bromophenyl)-acetic acid 
• 107-25-5 methoxyethene 
• 586-78-7 para-nitrophenyl bromide 
• 69628-98-4 2-(4-nitrophenyl)ethyl methyl ether 

Downstream Products

• 1606973-75-4 4-(3-chlorophenyl)-6-ethyl-N-(4-(2-methoxyethyl)phenyl)-1,3,5-triazin-2-amine 
• 915020-01-8 2-chloro-4-(2-methoxy-ethyl)-phenylamine 
• 91246-55-8 N-[4-(2-methoxy-ethyl)-phenyl]-acetamide 
• 56718-71-9 4-(2-methoxyethyl)phenol 

Relevant academic research and scientific papers

Preparation of vinyl ethers using a Wittig approach, and their subsequent hydrogenation employing continuous-flow processing

A methodology is reported for the preparation of various aromatic-functionalized vinyl ethers using a Wittig approach. The subsequent hydrogenation of the vinyl ether products to their saturated analogs is also performed and is streamlined by employing continuous-flow processing.

OXAZOLIDINONE HYDROXAMIC ACID COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

This invention pertains generally to treating bacterial infections using organic compounds of Formula I. In certain aspects, the invention pertains to treating infections caused by Gram-negative bacteria. (I) wherein X, Y, R1, R2, R3, R4 and R5 and defined herein.

5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE

The invention addresses the current need for selective and potent protein tyrosine kinase inhibitors by providing potent inhibitors of c-fms kinase. The invention is directed to the novel compounds of Formula I: or a salt, stereoisomer, tautomer, crystalline, polymorph, amorphous, solvate, hydrate, ester, prodrug or metabolite form thereof, wherein A, Y, Z, R101 and R200 are described in the specification.

HALOETHYL UREA COMPOUNDS AND THEIR USE TO ATTENUATE, INHIBIT OR PREVENT NON-CANCEROUS PATHOGENIC CELLULAR PROLIFERATION AND DISEASES ASSOCIATED THEREWITH

The present invention provides haloethyl urea compounds as described in Formula (I) and their use as anti-proliferative agent in the attenuation, inhibition, or prevention of non-cancerous cellular proliferation. These compounds are also provided for use as a therapeutic agent in the treatment of a disease or disorder, wherein pathogenesis of said disease or disorder is associated with non-cancerous pathogenic cellular proliferation.

HALOETHYL UREA COMPOUNDS AND THE USE THEREOF TO ATTENUATE, INHIBIT OR PREVENT CANCER CELL MIGRATION

The present invention provides haloethyl urea compounds as described in Formula (I) and their use as therapeutic agent in the attenuation, inhibition, or prevention of cancer cell migration and cancer cell proliferation.

A NEW ROUTE TO 4-(2-METHOXYETHYL)PHENOL VIA PALLADIUM-CATALYSED ARYLATION OF METHYL VINYL ETHER

Palladium on charcoal-catalysed reaction of methyl vinyl ether with 4-bromonitrobenzene, followed by hydrogenation and subsequent diazotation afforded 4-(2-methoxyethyl)phenol in 47percent total yield.